Results 191 to 200 of about 64,241 (304)

The issues and challenges of addressing the importation of unregistered pharmaceutical products in Malaysia. [PDF]

J Pharm Policy Pract
Lim LP, Bin Abdul Aziz MF.
europepmc   +1 more source

Insights into a long life without cancer: The case of the bowhead whale

Molecular Oncology, EarlyView.
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley   +1 more source

Trends in cross-border shopping for dietary supplements in South Korea with a focus on major types of health functional foods. [PDF]

Nutr Res Pract
Nam Y, Huang L, Rha JY, Suh B, Yoon J.
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Practice and challenges of humanitarian logistics management within the Ethiopian public pharmaceutical supply chain. [PDF]

BMC Health Serv Res
Tufa BB, Tebeka SM.
europepmc   +1 more source

Smart containers: quantifying the potential impact [PDF]

, 2016
Colle, Didier, Lannoo, Bart, Vannieuwenborg, Frederic, Verbrugge, Sofie   +3 more
core  

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Large language model driven transferable key information extraction mechanism for nonstandardized tables. [PDF]

Sci Rep
Hu R, Yang Y, Liu S, Li Z, Liu J, Ding X, Sun H, Ren L.   +7 more
europepmc   +1 more source

Barriers to investment in the agriculture and food sector in Ukraine [PDF]

, 2006
Nivyevskiy, Oleg, Strubenhoff, Heinz
core  

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

Molecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary, Jose Javier Bravo‐Cordero   +1 more
wiley   +1 more source